Ajouter à une liste
| Marché Fermé - Fonds 10:00:00 28/03/2024 | Varia. 5j. | Varia. 1 janv. | ||
| 103,5 EUR | +0,35 % |
|
-.--% | +0,11 % |
| Année en cours | +0,11 % |
Tous les gérants de la societe de gestion
| Nom | Depuis | Fonds gérés * | Total des encours * |
|---|---|---|---|
| Sylvain Poirier | 01/01/22 | 2 | 57 M EUR |
| Michael Bourke | 10/01/18 | 2 | 66 M EUR |
| Benjamin Hamidi | 29/07/13 | 3 | 133 M EUR |
| Giovanni Becchere | 01/04/15 | 15 | 173 M EUR |
| Ekaterina Chubarova | 02/11/07 | 34 | 386 M EUR |
| David Boivin | 01/01/22 | 43 | 3 443 M EUR |
| Kevin Sorel | 13/01/10 | 72 | 4 928 M EUR |
Profil
Actif total
au 29/02/2024
au 29/02/2024
4 M
EUR
Date de création
27/04/2020
Domicile
France
Zone géographique
Aucune restriction
Benchmark
Devise
EUR
Structure Juridique
FCP
PEA
NON
PEA-PME
NON
Type de capitalisation
Distribution
Stratégie du fonds
The Fund is a feeder of the SICAV Symbiotics Sicav II - ABN AMRO Impact Fund which pursues a double bottom line return, being both a sustainable positive impact as per ART 9 of Sustainable Finance Disclosure Regulation (SFDR) notably by targeting financial inclusion (microfinance), sustainable agriculture, community development, renewal energy, healthcare and education and offering an attractive financial return by investing primarily in Emerging and Frontier Economies (EFE) via debt instruments.No assurance can be given that the investment objectives will be achieved.
- Bourse
- Fonds ou OPCVM
- Fonds
- Equipe ABN Amro Symbiot Em Mrk Impt Debt AH EUR
